PD23-02 IS IT SAFE TO CONTINUE ANTI-PLATELET AND ANTI-COAGULATION THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY (PCNL)? A NESTED CASE CONTROL STUDY.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.